NVO

Share repurchase programme (21 January 2013)

[at noodls] – Bagsværd, Denmark, 21 January 2013 – On 9 November 2012 Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003 of 22 … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to […]

Novo Nordisk A/S: Status regarding Novo Nordisk’s holding of its own shares (31 December 2012) (2 January 2013)

[at noodls] – Read the full announcement in PDF format Bagsværd, Denmark, 2 January 2013 – In continuation of the company’s announcements dated 9 August 2012 and 9 November 2012 concerning planned share repurchase … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to […]

Novo Nordisk A/S – Share repurchase programme (2 January 2013)

[at noodls] – News On 9 November 2012 Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003 of 22 December 2003, also referred to … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to […]

Ryzodeg® (insulin degludec/insulin aspart) approved in Japan (25 December 2012)

[at noodls] – Bagsværd, Denmark, 25 December 2012 – Novo Nordisk today announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg® (insulin degludec/insulin aspart) for the treatment of … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to view […]

The final phase 3a trial for IDegLira completed, and FIAsp approved for phase 3 development (19 December 2012)

[at noodls] – Read the full announcement in PDF format Bagsværd, Denmark, 19 December 2012 – Novo Nordisk today announced the completion of the phase 3a programme for IDegLira, a fixed-ratio combination of insulin … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to […]

Novo Nordisk A/S : Share repurchase programme (17 December 2012)

[at noodls] – News On 9 November 2012 Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003 of 22 December 2003, also referred to … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to […]

Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives and associated persons on 5 December 2012 (6 December 2012)

[at noodls] – News In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares by the company’s board members, executives … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click […]

Novo Nordisk upgraded to ‘A1’ by Moody’s (5 December 2012)

[at noodls] – Bagsværd, Denmark, 5 December 2012 †Moody’s Investors Service has raised its long-term corporate credit rating on Novo Nordisk from A2 to A1 with a stable outlook. Furthermore, the Prime-1 short-term … moreView todays social media effects on NVOView the latest stocks trending across Twitter. Click to view dashboardSee who Novo is hiring next, click here to […]